1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma(CSHEIN)High Risk NeuroblastomaActive, not recruitingNot stated2025-12-12NCT07278674